FDA.reportPublic FDA data

Device Listing 1025213001

Listing Summary#

Listing key
1025213001
Premarket submission
K113033
Device
SODIUM CHLORDE INHALATION SOLUTION, 0.9% USP-3ML
Applicant
Nephron Pharmaceuticals Corp.
Product code
CAF
Decision date
2012-06-19